Summary:
Assess how well tetanus and meningoccal vaccination works in adult subjects who have been treated with Rocatinlimab for moderate-to-severe atopic dermatitis
Criteria:Ages 18-54 years
Diagnosis of atopic dermatitis that has been present for at least 12 months
History of inadequate response of topical cortosteroid
Qualified Participants May Receive:
Free Exams
Free Lab Work
Compensation for every study visit completed!
The study consist of only 10 clinic visits